CRMD
CRMD
NASDAQ · Pharmaceuticals

Cormedix Inc

$7.90
+0.12 (+1.54%)
As of Sep 23, 2:25 PM ET ·
Analyst Consensus
Strong Buy
11
Analysts
Moderate
Coverage
Buy 10 91%
Hold 1 9%
Sell 0 0%
Price Target
Analyst Price Target +564.6% upside
Low Target $41.99
Average Target $52.50
High Target $66.46
Current Price $7.90
Current
$7.90
Target
$52.50
$41.99 $52.50 avg $66.46
Scenario Analysis
Bear Case
$41.99
431.5%
Low target
Base Case
$52.50
+564.6%
Avg target
Bull Case
$66.46
+741.3%
High target
Risk/Reward
1.7x
Balanced
Price in Context
52-Week High
$13.02
-39.3% from high
52-Week Low
$6.13
+28.9% from low
Target vs 52W High
$52.50
+303.2% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 38 79% $1,330.33 +15.8%
RDY
Dr. Reddy's Laboratories
Strong Sell 45 31% +0.0%
JNJ
Johnson & Johnson
Buy 31 71% $299.55 +11.9%
MRK
Merck & Co. Inc.
Buy 36 72% $159.27 +7.9%
PFE
Pfizer Inc.
Hold 36 39% $33.90 +20.9%
BMY
Bristol-Myers Squibb Co
Hold 35 43% $174.50 +180.3%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -38.0%
ZTS
Zoetis Inc
Hold 24 50% $209.87 +192.4%